IXC invex therapeutics ltd

Ann: Invex Granted Key European Patent for Exenatide, page-5

  1. 795 Posts.
    lightbulb Created with Sketch. 45
    Great to see our patent position growing. Was hoping this would be a phase III trial announcement but I guess the wait continues, thats biotech for you
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.0¢
Change
0.000(0.00%)
Mkt cap ! $6.763M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 5 9.2¢
 

Sellers (Offers)

Price($) Vol. No.
9.6¢ 5165 1
View Market Depth
Last trade - 11.00am 14/07/2025 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.